Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screeningCorrigendumSequential cancer mutations in cultured human intestinal stem cellsLive imaging of cell division in 3D stem-cell organoid culturesGenome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumorsMedium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids
author
nationality
type
label
René M Overmeer